Completed
Topics
On June 27 and 28, 2022, the National Cancer Policy Forum will host a public workshop that will consider the current state of knowledge regarding risk factors for cancer and strategies for interventions across multiple levels to reduce cancer risk.
Featured publication
Workshop
ยท2023
The National Academies National Cancer Policy Forum hosted a Summer 2022 workshop to explore the current state of knowledge regarding risk factors for cancer and best practices for cancer prevention and risk reduction interventions. Speakers reviewed the current evidence base, examined best practice...
View details
Description
A planning committee will organize and host a 1.5-day public workshop that will consider the current state of knowledge regarding risk factors for cancer and strategies for interventions across multiple levels to reduce cancer risk. The workshop will feature invited presentations and panel discussions on topics that may include:
-
An overview of the current evidence base for modifiable (e.g., environmental and behavioral) risk factors for cancer, including consideration of how these factors are distributed across populations and influenced by socioeconomic factors.
-
Best practices and innovative approaches to implement population-based cancer prevention strategies, including the potential for collaborations with other disease prevention efforts.
-
Opportunities to overcome challenges in the delivery of cancer prevention services within communities and health care settings, including consideration of specific strategies for low-resource areas.
-
Opportunities to improve implementation of vaccine-based interventions for cancer prevention, as well as for pharmacological and surgical interventions to reduce cancer risk.
-
Methods for assessing efficacy of programs and inventions for cancer prevention and risk reduction, including the identification and validation of biomarkers as surrogate endpoints.
The planning committee will develop the agenda for the workshop sessions, select and invite speakers and discussants, and moderate the discussions. A proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines.
Collaborators
Sponsors
American Association for Cancer Research
American Cancer Society
American College of Radiology
American Society of Clinical Oncology
Association of American Cancer Institutes
Association of Community Cancer Centers
Bristol Myers Squibb
Cancer Support Community
Centers for Disease Control and Prevention (CDC)
CEO Roundtable on Cancer
Flatiron Health
Merck
National Cancer Institute
National Patient Advocate Foundation
Novartis Oncology
Oncology Nursing Society
Pfizer Inc.
Sanofi
Society for Immunotherapy of Cancer
Staff
Annalee Espinosa Gonzales
Lori Brenig
Rachel Austin
Sharyl Nass
Francis Amankwah